Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Patients should never discontinue semaglutide or alter dosing without medical guidance, as this may compromise glycemic control or weight management outcomes
It is the target for several FDA-approved antidiabetic medications called incretin mimetics: These incretin mimetics are glucagon-like peptide 1 (GLP-1) analogs that mimic the physiological action of GLP-1 and thereby potentiates the incretin effect in type 2 diabetic patients
You will receive ongoing care and support while subscribed to our service
Upper arm: The outer area of the upper arm
References Langer HT, Gilmore NK, Hayden CMT, et al
US$ 20.80
US$ 24.93
US$ 20.86
